Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4523993 Target Snapshot

Programmed cell death protein 1/Programmed cell death 1 ligand 1 · PROTEIN COMPLEX · Homo sapiens

4,178Compounds
296Assays
2Approved Drugs
6,198.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q15116. Use UniProt Q15116 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q15116 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Programmed cell death protein 1/Programmed cell death 1 ligand 1 as ChEMBL target CHEMBL4523993, mapped to UniProt Q15116. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Programmed cell death protein 1/Programmed cell death 1 ligand 1
PROTEIN COMPLEX · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL4523993
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q15116
Programmed cell death protein 1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Programmed cell death protein 1/Programmed cell death 1 ligand 1 is the right protein anchor across sources, using UniProt Q15116 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelProgrammed cell death protein 1
UniProt AccessionQ15116
Component TypeProtein
Sequence Length288 aa

Programmed cell death protein 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Programmed cell death protein 1/Programmed cell death 1 ligand 1, mapped to UniProt Q15116. ChEMBL maps the protein component as Programmed cell death protein 1. Sequence length is 288 aa.

Mapped IDQ15116
Review nameProgrammed cell death protein 1/Programmed cell death 1 ligand 1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
2
Phase I
Assay Mix

Activity Type Distribution

IC505,693.0
KI1.0
EC50504.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5411833 11.0 IC50 0.01 Preclinical
CHEMBL6041367 10.49 IC50 0.032 Preclinical
CHEMBL5816891 10.47 IC50 0.034 Preclinical
CHEMBL5182195 10.4 IC50 0.04 Preclinical
CHEMBL6061706 10.4 IC50 0.04 Preclinical
CHEMBL4865838 10.29 IC50 0.051 Preclinical
CHEMBL4862360 10.24 IC50 0.058 Preclinical
CHEMBL5743690 10.22 IC50 0.06 Preclinical
CHEMBL5777528 10.22 IC50 0.06 Preclinical
CHEMBL5831012 10.22 IC50 0.06 Preclinical
Distribution

pChEMBL Value Distribution

79
5.0
389
5.5
224
6.0
336
6.5
499
7.0
561
7.5
321
8.0
262
8.5
397
9.0
717
9.5
pChEMBL
Approved Drugs

Approved Drugs

PYRVINIUM
CHEMBL1201303
Approved 1982
Assay Landscape

Assay Landscape

296
Total Assays
3,591
Tested Compounds
1
Assay Types
Binding — 296 assays, 3,591 compounds
BAO Format Assays Compounds Avg pChEMBL
protein complex format 194 2,826 8.3
cell-based format 69 381 7.4
assay format 22 384 7.7
tissue-based format 11 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine